Effect of introducing high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children
This is the main finding of a recent article based on data from The Streptococcus pneumoniae Invasive Disease network (SpIDnet).
Assessing seasonal influenza vaccine effectiveness
On 3 December 2015, ECDC hosts a technical meeting to discuss influenza vaccine effectiveness studies and how they can best meet public health needs as well as regulatory requirements.
Initial studies on seasonal influenza vaccine effectiveness for 2013/2014
The authors used a test-negative case control design to estimate the 2013/14 influenza vaccine effectiveness (VE) in patients seen with influenza-like illness as outpatients in Spain during December 2013-January 2014.
Annual influenza vaccine effectiveness meeting 2013 – summary of discussions on obtained results and recommended future research focus
Influenza vaccine experts from thirteen EU countries and invited guests from Canada and the US gathered for three days July 1-3, 2013 in Annecy, France to report and discuss obtained national and pooled multi-country seasonal influenza vaccine effectiveness (VE) obtained in the 2012/2013 season. The meeting was co-organized by ECDC and Epiconcept.
Lower than usual: early influenza vaccine effectiveness in parts of Europe in season 2011/12
A rapid communication published on April 12th 2012 describes the early results of the annual multicentre case-control study undertaken by the ECDC sponsored I-MOVE consortium whose work is coordinated by an Epiconcept team
Study shows decreased vaccine effectiveness of the seasonal influenza vaccine; ECDC Director urges to develop more effective vaccines
Preliminary results of European vaccine effectiveness study show decreased protective effect of the seasonal influenza vaccine in 2011/2012 season. ECDC Director Marc Sprenger calls for action.
The importance of analyses of antigenic match and monitoring influenza vaccine effectiveness
Influenza viruses pose a particular challenge for those designing vaccines for humans. Much of the protective immunity that humans have against these viruses following natural infection or vaccination is due to immunological recognition of the haemagglutinin (HA) surface glycoprotein.
Systematic review and meta-analysis concerning the efficacy and effectiveness of seasonal influenza vaccines – (part 1)
This is an authoritative independent evidence-based review and meta-analysis of the efficacy and effectiveness of influenza vaccines. It confines itself to trials and observational studies where diagnostic tests confirmed influenza infection as the end point.